NASDAQ:ABCM

Abcam News Headlines

$19.56
-0.11 (-0.56 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.51
Now: $19.56
$19.88
50-Day Range
$19.22
MA: $20.90
$23.83
52-Week Range
$17.71
Now: $19.56
$24.69
Volume136,914 shs
Average Volume179,044 shs
Market Capitalization$4.43 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Abcam (NASDAQ ABCM) News Headlines Today

SourceHeadline
Abcam plcs (NASDAQ:ABCM) Lock-Up Period Will Expire  on April 20thAbcam plc's (NASDAQ:ABCM) Lock-Up Period Will Expire on April 20th
americanbankingnews.com - April 13 at 1:18 AM
Abcam (NASDAQ:ABCM) Shares Gap Down to $19.89Abcam (NASDAQ:ABCM) Shares Gap Down to $19.89
americanbankingnews.com - April 6 at 11:00 AM
Abcam plc (NASDAQ:ABCM) Receives Average Rating of "Hold" from AnalystsAbcam plc (NASDAQ:ABCM) Receives Average Rating of "Hold" from Analysts
americanbankingnews.com - April 3 at 6:40 AM
Short Interest in Abcam plc (NASDAQ:ABCM) Expands By 63.1%Short Interest in Abcam plc (NASDAQ:ABCM) Expands By 63.1%
americanbankingnews.com - March 31 at 3:04 AM
Abcam is Now OversoldAbcam is Now Oversold
nasdaq.com - March 8 at 3:01 PM
Abcam plc reports 1H resultsAbcam plc reports 1H results
seekingalpha.com - March 8 at 7:25 AM
Abingdon Healt. Regulatory NewsAbingdon Healt. Regulatory News
lse.co.uk - February 10 at 7:15 PM
Abingdon Health PLC: Abingdon Health signs collaboration and co-marketing agreement with AbcamAbingdon Health PLC: Abingdon Health signs collaboration and co-marketing agreement with Abcam
finanznachrichten.de - February 9 at 8:17 AM
Abingdon Health signs collaboration and co-marketing agreement with AbcamAbingdon Health signs collaboration and co-marketing agreement with Abcam
markets.businessinsider.com - February 9 at 8:17 AM
Abcam plc Half Year Trading UpdateAbcam plc Half Year Trading Update
finance.yahoo.com - January 11 at 7:39 AM
Abcam PLC ADRAbcam PLC ADR
barrons.com - November 15 at 11:35 PM
ABCM.OQ - Abcam Plc Profile | ReutersABCM.OQ - Abcam Plc Profile | Reuters
reuters.com - November 13 at 9:08 PM
Lydia Seymour joins Cambridge Healthcare Research as Head of HR, formerly of Abcam and FluidigmLydia Seymour joins Cambridge Healthcare Research as Head of HR, formerly of Abcam and Fluidigm
markets.businessinsider.com - November 12 at 2:37 PM
Antigen ELISA Kit Market Drive Highest Growth By 2030 With Leading Players(2021-2030)|| Abcam, XpressBio, Affinity BiologicalsAntigen ELISA Kit Market Drive Highest Growth By 2030 With Leading Players(2021-2030)|| Abcam, XpressBio, Affinity Biologicals
marketwatch.com - November 9 at 5:19 AM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.